In models of lung cancer, genetic knockout of progranulin (PGRN)-a protein known to suppress immune responses and promote tumor progression- resulted in robust upregulation of CCL3 in CD8+ T cells, correlating with enhanced infiltration, proliferation, and effector function. The gene discussed is GRN; the disease is lung carcinoma.